{"entity":{"type":"insider","cik":"0001744573","url":"/insider/0001744573","json_url":"/insider/0001744573.json","name":"Allouche Cyril","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2018-07-06","last":"2019-03-19","span_basis":"filed_date"},"name_variants":[{"name":"Allouche Cyril","source":"filing","n_filings":6,"first_seen":"2018-07-06","last_seen":"2019-03-19"}],"transactions":[{"id":8576260,"accession":"0001479290-19-000036","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001479290-19-000036","line_url":"/filing/0001479290-19-000036#line-2","is_derivative":false,"issuer_cik":"0001479290","issuer_name":"Revance Therapeutics, Inc.","issuer_ticker":"RVNC","issuer_name_source":null,"issuer_url":"/issuer/0001479290","owner_cik":"0001744573","owner_name":"Allouche Cyril","owner_display_name":"Allouche Cyril","owner_url":"/insider/0001744573","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":498.0,"shares_display":"498","price_per_share":15.48,"price_display":"15.48","price_state":"stated","total_value":7709.04,"total_display":"7,709.04","total_whole":"7,709","shares_owned_after":6400.0,"shares_owned_after_display":"6,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-18","filed_date":"2019-03-19","scope":"insider"},{"id":7795798,"accession":"0001479290-19-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001479290-19-000010","line_url":"/filing/0001479290-19-000010#line-2","is_derivative":false,"issuer_cik":"0001479290","issuer_name":"Revance Therapeutics, Inc.","issuer_ticker":"RVNC","issuer_name_source":null,"issuer_url":"/issuer/0001479290","owner_cik":"0001744573","owner_name":"Allouche Cyril","owner_display_name":"Allouche Cyril","owner_url":"/insider/0001744573","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":625.0,"shares_display":"625","price_per_share":17.77,"price_display":"17.77","price_state":"stated","total_value":11106.25,"total_display":"11,106.25","total_whole":"11,106","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-22","filed_date":"2019-01-23","scope":"insider"},{"id":7890954,"accession":"0001479290-19-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001479290-19-000006","line_url":"/filing/0001479290-19-000006#line-1","is_derivative":false,"issuer_cik":"0001479290","issuer_name":"Revance Therapeutics, Inc.","issuer_ticker":"RVNC","issuer_name_source":null,"issuer_url":"/issuer/0001479290","owner_cik":"0001744573","owner_name":"Allouche Cyril","owner_display_name":"Allouche Cyril","owner_url":"/insider/0001744573","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":375.0,"shares_display":"375","price_per_share":19.48,"price_display":"19.48","price_state":"stated","total_value":7305.0,"total_display":"7,305.00","total_whole":"7,305","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-03","filed_date":"2019-01-04","scope":"insider"},{"id":6792300,"accession":"0001479290-18-000121","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001479290-18-000121","line_url":"/filing/0001479290-18-000121#line-1","is_derivative":false,"issuer_cik":"0001479290","issuer_name":"Revance Therapeutics, Inc.","issuer_ticker":"RVNC","issuer_name_source":null,"issuer_url":"/issuer/0001479290","owner_cik":"0001744573","owner_name":"Allouche Cyril","owner_display_name":"Allouche Cyril","owner_url":"/insider/0001744573","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":491.0,"shares_display":"491","price_per_share":20.66,"price_display":"20.66","price_state":"stated","total_value":10144.06,"total_display":"10,144.06","total_whole":"10,144","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-20","filed_date":"2018-11-21","scope":"insider"},{"id":5987518,"accession":"0001479290-18-000114","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001479290-18-000114","line_url":"/filing/0001479290-18-000114#line-2","is_derivative":false,"issuer_cik":"0001479290","issuer_name":"Revance Therapeutics, Inc.","issuer_ticker":"RVNC","issuer_name_source":null,"issuer_url":"/issuer/0001479290","owner_cik":"0001744573","owner_name":"Allouche Cyril","owner_display_name":"Allouche Cyril","owner_url":"/insider/0001744573","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2188.0,"shares_display":"2,188","price_per_share":23.72,"price_display":"23.72","price_state":"stated","total_value":51899.36,"total_display":"51,899.36","total_whole":"51,899","shares_owned_after":4750.0,"shares_owned_after_display":"4,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-09","filed_date":"2018-11-09","scope":"insider"},{"id":6159187,"accession":"0001479290-18-000095","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001479290-18-000095","line_url":"/filing/0001479290-18-000095#line-1","is_derivative":false,"issuer_cik":"0001479290","issuer_name":"Revance Therapeutics, Inc.","issuer_ticker":"RVNC","issuer_name_source":null,"issuer_url":"/issuer/0001479290","owner_cik":"0001744573","owner_name":"Allouche Cyril","owner_display_name":"Allouche Cyril","owner_url":"/insider/0001744573","role":"Officer (Principal Financial Officer)","role_mark":"O","role_mark_label":"Officer (Principal Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":393.0,"shares_display":"393","price_per_share":28.35,"price_display":"28.35","price_state":"stated","total_value":11141.55,"total_display":"11,141.55","total_whole":"11,142","shares_owned_after":4750.0,"shares_owned_after_display":"4,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-06","filed_date":"2018-07-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001479290","name":"Revance Therapeutics, Inc.","url":"/issuer/0001479290","role":"Officer (Principal Accounting Officer)","n_filings":6,"first_seen":"2018-07-06","last_seen":"2019-03-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001744573","retrieved_at":"2026-08-27T13:16:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}